首页> 外文期刊>Therapeutic Drug Monitoring >Protein binding of flucloxacillin in neonates.
【24h】

Protein binding of flucloxacillin in neonates.

机译:氟氯西林在新生儿中的蛋白质结合。

获取原文
获取原文并翻译 | 示例
           

摘要

The isoxazolyl penicillins, including flucloxacillin, have the highest levels of plasma protein binding among the semisynthetic penicillins. Because only the free fraction of the penicillin is pharmacologically active, it would be useful to measure both protein-bound and free flucloxacillin to determine its protein binding. Until now, flucloxacillin protein binding in newborn infants has been investigated in only two studies with relatively small populations. In the present study, flucloxacillin protein binding was investigated in 56 (preterm) infants aged 3 to 87 days (gestational age, 25-41 weeks). Surplus plasma samples from routine gentamicin assays of each infant were collected and combined to obtain a sufficiently large sample for analysis. Free flucloxacillin was separated from protein-bound flucloxacillin using ultrafiltration. Reversed-phase high-performance liquid chromatography with ultraviolet detection was used to measure free flucloxacillin concentrations in ultrafiltrate and total flucloxacillin concentrations in pooled plasma. Flucloxacillin protein binding was 74.5% +/- 13.1% (mean +/- standard deviation) with a high variability among the infants (34.3% to 89.7%). High Pearson correlations were found between protein binding and the covariates-plasma albumin concentration (r = 0.804, P < 0.001, n = 18) and plasma creatinine concentration (r = -0.601, P < 0.001, n = 45). Statistically significant but less striking correlations were found between protein binding and gestational age, postconceptional age, body weight, and triglyceride concentration. Because of the high variability of protein binding among infants, it is difficult to devise a flucloxacillin dosage regimen effective for all infants. Individualized dosing, based on free flucloxacillin concentrations, might help to optimize treatment of late-onset neonatal sepsis, but practical obstacles will probably prevent analysis of free flucloxacillin concentrations in newborn infants on a routine basis.
机译:在半合成青霉素中,包括氟氯西林在内的异恶唑基青霉素的血浆蛋白结合水平最高。由于仅青霉素的游离部分具有药理活性,因此测定结合蛋白和游离氟氯西林以确定其蛋白结合将是有用的。迄今为止,仅在两项人口相对较少的研究中对新生儿氟氯西林蛋白的结合进行了研究。在本研究中,对56例3至87天(胎龄为25-41周)的早产儿进行了氟氯西林蛋白结合的研究。收集每个婴儿常规庆大霉素测定的多余血浆样品,并合并以获得足够大的样品进行分析。使用超滤将游离的氟氯西林与结合蛋白的氟氯西林分离。采用紫外检测的反相高效液相色谱法测量超滤液中游离氟氯西林的浓度和合并血浆中氟氯西林的总浓度。氟氯西林蛋白结合率为74.5%+/- 13.1%(平均+/-标准偏差),婴儿之间的变异性较高(34.3%至89.7%)。在蛋白质结合与协变量-血浆白蛋白浓度(r = 0.804,P <0.001,n = 18)和血浆肌酐浓度(r = -0.601,P <0.001,n = 45)之间发现高的皮尔逊相关性。在蛋白质结合与胎龄,孕后年龄,体重和甘油三酸酯浓度之间发现统计学上显着但不那么显着的相关性。由于婴儿之间蛋白质结合的高度可变性,因此难以设计出对所有婴儿均有效的氟氯西林剂量方案。基于游离氟氯西林浓度的个性化给药可能有助于优化新生儿迟发性败血症的治疗,但实际障碍可能会阻止常规分析新生儿氟氯西林浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号